Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Head and Neck Cancer News
HEAD AND NECK CANCER ADVISOR
Head and Neck Cancer News
Cancer Patients Reported Symptoms of PTSD During First Year of COVID-19 Pandemic
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.
Classifying Oropharyngeal Cancer by p16 Status Alone Deemed Insufficient
Oropharyngeal cancer patients who have discordant p16 and HPV status have worse prognosis than patients who have p16+/HPV+ disease, a study suggests.
Social Vulnerability Tied to Worse Pediatric Head and Neck Cancer Outcomes
Increasing social vulnerability is associated with significant decreases in surveillance and survival time among pediatric patients with head and neck cancers.
Quitting Smoking Tied to Better Survival in Head and Neck Cancer
Among patients with head and neck cancer, smoking cessation for more than 10 years is associated with reduced overall mortality and cancer-specific mortality.
Docetaxel Acts as Radiosensitizer in Head and Neck Cancer
Adding docetaxel to radiation improves outcomes for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase 2/3 trial suggests.
Larotrectinib Bests Standard Care for TRK-Fusion Positive Cancers
Larotrectinib prolongs survival when compared with non-TRK inhibitor standard care in adults with TRK fusion-positive cancers, a study suggests.
“One-Stop Shop” Screening Centers May Improve Cancer Detection
Centers that perform comprehensive cancer screening in a single appointment may enable earlier cancer diagnosis.
Turmeric Mouthwash Reduces Severity of Oral Mucositis in Head and Neck Cancer
Researchers compared a turmeric mouthwash to benzydamine mouthwash in patients with head and neck cancer.
Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Risk of Suicide Highest in the First 6 Months After a Cancer Diagnosis
Cancer patients have an increased risk of suicide when compared with the general population in the United States, a study suggests.
Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders
Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 major psychiatric disorders.
Patients Undergoing Cancer Surgery Have Higher Risk of Suicide
Patients undergoing cancer surgery have an increased risk of suicide compared with the general population, a new study suggests.
Smaller, Rural Oncology Practices Slower to Adopt Approved Immunotherapies
Some oncology practices are less likely than others to adopt immunotherapies within 2 years of regulatory approval, a study suggests.
Many Thyroid Cancer Survivors Cite Inadequate Pretreatment Understanding
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
Outcomes Worse for Black Patients With Head and Neck Cancer in Clinical Trials
Outcomes were worse for Black patients than for White patients, despite similar access to care and socioeconomic status.
Intracranial Metastasis of Esthesioneuroblastoma May Occur 19 Years After Remission
Recurrence of esthesioneuroblastoma with non-contiguous intracranial metastasis is possible 19 years after remission, a review suggests.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Durvalumab Plus IMRT No Better Than Cetuximab Plus IMRT in Head and Neck Cancer
Durvalumab plus IMRT proved no more effective than cetuximab plus IMRT in patients with treatment-naïve, locoregionally advanced head and neck squamous cell carcinoma.
COVID-19 Vaccination Should Not Interrupt ICI Therapy, Researchers Say
COVID-19 vaccination is safe for cancer patients receiving immune checkpoint inhibitors and should not interrupt therapy, according to researchers.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...